Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
4.280
-0.300 (-6.55%)
Oct 6, 2026, 4:00 PM EDT - Market closed
Myriad Genetics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains $4 → $8 | Buy | Maintains | $4 → $8 | +86.92% | Oct 2, 2026 |
Unknown Analyst UBS No rating | UBS | Hold Initiates $6 → $3.6 | Hold | Initiates | $6 → $3.6 | -15.89% | Sep 9, 2026 |
| Piper Sandler | Piper Sandler | Sell Downgrades $8.5 → $2 | Sell | Downgrades | $8.5 → $2 | -53.27% | Sep 1, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Sell Maintains $2.5 | Sell | Maintains | $2.5 | -41.59% | Aug 21, 2026 |
| Stephens | Stephens | Hold Reiterates $3 | Hold | Reiterates | $3 | -29.91% | Aug 18, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 4, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $4 → $3.2 | Sell | Reiterates | $4 → $3.2 | -25.23% | Aug 3, 2026 |
| TD Cowen | TD Cowen | Hold Reiterates $6 → $4 | Hold | Reiterates | $6 → $4 | -6.54% | Jul 31, 2026 |